Therapieinduzierte Tumorregression und Regressionsgrading bei Lungenkarzinomen

Albain KS, Rusch V, Crowley JJ et al (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest oncology group phase II study 8805. J Clin Oncol 13:1880–1892

Blaauwgeers JL, Kappers I, Klomp HM et al (2013) Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior sulcus. Virchows Arch 462:547–556

Broermann P, Junker K, Brandt B et al (2002) Trimodality treatment in stage III non-small cell lung cancer: Prognostic impact of K-ras mutations after neoadjuvant therapy. Cancer 94:2055–2062

Caglar HB, Baldini EH, Othus M et al (2009) Outcomes of patients with stage III non-small cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer 115:4156–4166

Choi NC, Carey RW, Daly W et al (1997) Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol 15:712–722

Eberhardt W, Wilke H, Stamatis G et al (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16:622–634

Johnson DH, Turrisi AT, Pass HI (1996) Combined modality treatment for locally advanced non – small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH (Hrsg) Lung cancer: principles and practice. Lippincott, New York, S 863–873

Junker K, Krapp D, Müller KM (1995) Kleinzelliges Bronchialkarzinom nach Chemotherapie – Morphologische Befunde. Pathologe 16:217–222

Junker K, Thomas M, Schulmann K et al (1997) Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J Cancer Res Clin Oncol 123:469–477

Junker K (2001) Tumorregression bösartiger Lungentumoren. akademos Wissenschaftsverlag, Hamburg

Junker K, Langner K, Klinke F et al (2001) Grading of tumor regression in non-small cell lung cancer: morphology and prognosis. Chest 120:1584–1591

Junker K, Müller KM, Bosse U et al (2003) Apoptose und Tumorregression bei neoadjuvant behandelten lokal fortgeschrittenen nicht-kleinzelligen Lungenkarzinomen. Pathologe 24:214–219

Junker K, Müller KM, Abker S et al (2004) Zelluläre Veränderungen nicht-kleinzelliger Lungenkarzinome nach neoadjuvanter Therapie. Pathologe 25:193–201

Junker K (2004) Therapieinduzierte morphologische Veränderungen bösartiger Lungentumoren. Pathologe 25:475–480

Junker K, Stachetzki U, Rademacher D et al (2005) HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy. Lung Cancer 48:59–67

Langner K, Müller KM, Junker K (2000) Differenzierungswandel kleinzelliger Lungenkarzinome nach Chemotherapie. Pathologe 21:358–363

Langner K, Thomas M, Klinke F et al (2003) Neoadjuvante Therapie des nicht-kleinzelligen Lungenkarzinoms – Prognostische Relevanz des „mediastinalen Downstagings“. Chirurg 74:42–49

Liu-Jarin X, Stoopler MB, Raftopoulos H et al (2003) Histological assessment of non-small cell lung carcinoma after neoadjuvant therapy. Mod Pathol 16:1102–1106

Pisters KMW, Kris MG, Gralla RJ et al (1993) Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trials. J Clin Oncol 11:1757–1762

Takeda S, Maeda H, Yamaguchi T et al (2006) Results of pulmonary resection following neoadjuvant therapy for locally advanced (IIIA-IIIB) lung cancer. Eur J Cardiothorac Surg 30:184–189

Thomas M, Rübe C, Semik M et al (1997) Neoadjuvante multimodale Therapie im Stadium IIIA des nicht-kleinzelligen Bronchialkarzinoms. Dtsch Med Wochenschr 122:993–998

Thomas M, Rübe C, Semik M et al (1999) Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185NEU. Eur Respir J 13:424–429

Thomas M, Rübe C, Semik M et al (1999) Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer. J Clin Oncol 17:1185–1193

Thomas M, Rübe C, Hoffknecht P et al (2008) Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 9:636–648

Wyllie AH (1993) Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67:205–208

Yamane Y, Ishii G, Goto K et al (2010) A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy – the prognostic importance of the area of residual tumor. J Thorac Oncol 5:49–55